scholarly article | Q13442814 |
retracted paper | Q45182324 |
P6179 | Dimensions Publication ID | 1037435127 |
P356 | DOI | 10.1038/NATURE08456 |
P698 | PubMed publication ID | 19829383 |
P5875 | ResearchGate publication ID | 38011792 |
P2093 | author name string | Shigeaki Kato | |
Hiroshi Shibuya | |||
Takahiro Matsumoto | |||
Yoko Yamamoto | |||
Mi-Sun Kim | |||
Hirochika Kitagawa | |||
Ichiro Takada | |||
Ken-ichi Takeyama | |||
Takeshi Kondo | |||
Fumiaki Ohtake | |||
Sally Fujiyama | |||
Sayuri Takahashi | |||
Min-Young Youn | |||
Ikuko Yamaoka | |||
Yuko Shirode | |||
P2860 | cites work | Cyclical DNA methylation of a transcriptionally active promoter | Q40005351 |
Dioxin receptor is a ligand-dependent E3 ubiquitin ligase | Q40152793 | ||
Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. | Q40176354 | ||
Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching | Q40413870 | ||
The promoter of the human 25-hydroxyvitamin D3 1 alpha-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1 alpha,25(OH)2D3. | Q41016117 | ||
The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. | Q41731155 | ||
DNA Cytosine demethylation: are we getting close? | Q46182757 | ||
Histone lysine demethylases and their impact on epigenetics. | Q53626346 | ||
A cell cycle-dependent co-repressor mediates photoreceptor cell-specific nuclear receptor function | Q28115491 | ||
DNA methyltransferase Dnmt1 associates with histone deacetylase activity | Q28141500 | ||
The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites | Q28145111 | ||
Association of CBP/p300 acetylase and thymine DNA glycosylase links DNA repair and transcription | Q28203698 | ||
Combinatorial control of gene expression by nuclear receptors and coregulators | Q28209095 | ||
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells | Q28212826 | ||
Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning | Q28508915 | ||
Perceptions of epigenetics | Q29547310 | ||
Epigenetics in human disease and prospects for epigenetic therapy | Q29547437 | ||
Stability and flexibility of epigenetic gene regulation in mammalian development | Q29615922 | ||
Epigenetics: a landscape takes shape | Q29616623 | ||
A decade of molecular biology of retinoic acid receptors | Q29619944 | ||
DEMETER DNA glycosylase establishes MEDEA polycomb gene self-imprinting by allele-specific demethylation. | Q33931372 | ||
Methyl-CpG-binding proteins. Targeting specific gene repression. | Q34106217 | ||
Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. | Q34140253 | ||
Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation | Q34324051 | ||
HP1 and the dynamics of heterochromatin maintenance | Q35741016 | ||
Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter | Q35859594 | ||
Progress, paradox, and potential: parathyroid hormone research over five decades | Q37023000 | ||
5-Methylcytosine DNA glycosylase activity is also present in the human MBD4 (G/T mismatch glycosylase) and in a related avian sequence | Q38307104 | ||
Human thymine DNA glycosylase binds to apurinic sites in DNA but is displaced by human apurinic endonuclease 1. | Q38330113 | ||
Transient cyclical methylation of promoter DNA. | Q40005345 | ||
P433 | issue | 7266 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1007-1012 | |
P577 | publication date | 2009-10-01 | |
P1433 | published in | Nature | Q180445 |
P5824 | retracted by | Retraction: DNA demethylation in hormone-induced transcriptional derepression | Q49130490 |
P1476 | title | DNA demethylation in hormone-induced transcriptional derepression | |
P478 | volume | 461 |
Q26859884 | "Seq-ing" insights into the epigenetics of neuronal gene regulation |
Q40593350 | 5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes |
Q33832689 | A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3. |
Q41979413 | A genome-wide methylation study of severe vitamin D deficiency in African American adolescents |
Q34673365 | A potential role for CHH DNA methylation in cotton fiber growth patterns |
Q41553016 | Acetylation- and Methylation-Related Epigenetic Proteins in the Context of Their Targets |
Q37984958 | Active DNA demethylation by Gadd45 and DNA repair |
Q34024482 | Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels |
Q26825595 | Active DNA demethylation in mammalian preimplantation embryos: new insights and new perspectives |
Q34129576 | Active DNA demethylation: many roads lead to Rome. |
Q44889856 | Active demethylation of the IL-2 Promoter in CD4+ T cells is mediated by an inducible DNA glycosylase, Myh. |
Q37234787 | Aldosterone reprograms promoter methylation to regulate αENaC transcription in the collecting duct |
Q61312073 | Androgen Receptor Mutations Are Associated with Altered Epigenomic Programming as Evidenced by HOXA5 Methylation |
Q34162748 | Androgen-regulated transcriptional control of sialyltransferases in prostate cancer cells |
Q42576933 | Apoptosis and DNA methylation. |
Q28078441 | Base Excision Repair, a Pathway Regulated by Posttranslational Modifications |
Q36651017 | Biochemical reconstitution of TET1-TDG-BER-dependent active DNA demethylation reveals a highly coordinated mechanism |
Q37867211 | Biological functions of methyl-CpG-binding proteins |
Q38676378 | Cell type-specific target selection by combinatorial binding of Smad2/3 proteins and hepatocyte nuclear factor 4alpha in HepG2 cells |
Q36987523 | Cell-Specific Polymorphism and Hormonal Regulation of DNA Methylation in Scavenger Receptor Class B, Type I. |
Q37805660 | Chromatin architecture and the regulation of nuclear receptor inducible transcription. |
Q34080232 | Chromatin remodeling in mammary gland differentiation and breast tumorigenesis |
Q83663137 | Comment on "Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice" |
Q36638670 | Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis |
Q37866372 | Control of nuclear receptor function by local chromatin structure. |
Q33802703 | Coordinated chromatin control: structural and functional linkage of DNA and histone methylation |
Q27678915 | Crystal Structure of Human Methyl-Binding Domain IV Glycosylase Bound to Abasic DNA |
Q34164873 | Cytidine deaminases: AIDing DNA demethylation? |
Q38559112 | Cytochrome P450 Vitamin D Hydroxylases in Inflammation and Cancer. |
Q37771487 | Cytochromes P450 are essential players in the vitamin D signaling system |
Q52591890 | DNA Methylation and Histone Modification in Hypertension. |
Q59198931 | DNA Repair and the Control of DNA Methylation |
Q37878076 | DNA demethylases: a new epigenetic frontier in drug discovery. |
Q38037625 | DNA demethylation by TDG. |
Q26830166 | DNA glycosylases: in DNA repair and beyond |
Q34174778 | DNA methylation and demethylation in mammals |
Q36439450 | DNA methylation and histone modifications are associated with repression of the inhibin α promoter in the rat corpus luteum |
Q42498840 | DNA methylation contributes to the regulation of sclerostin expression in human osteocytes. |
Q48707994 | DNA methylation reprogramming and DNA repair in the mouse zygote. |
Q35176962 | DNA methylation status predicts cell type-specific enhancer activity. |
Q35017709 | DNA methylation within the I.4 promoter region correlates with CYPl19A1 gene expression in human ex vivo mature omental and subcutaneous adipocytes. |
Q34218919 | DNA methylation: superior or subordinate in the epigenetic hierarchy? |
Q40251824 | Direct repair of 3,N(4)-ethenocytosine by the human ALKBH2 dioxygenase is blocked by the AAG/MPG glycosylase |
Q34057105 | Distinct epigenomic features in end-stage failing human hearts |
Q37429943 | Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis |
Q34087810 | Epigenetic GABAergic targets in schizophrenia and bipolar disorder |
Q55418991 | Epigenetic Regulation of Aldosterone Synthase Gene by Sodium and Angiotensin II. |
Q36415128 | Epigenetic control of metastasis-associated protein 1 gene expression by hepatitis B virus X protein during hepatocarcinogenesis. |
Q37901300 | Epigenetic mechanisms and cancer: an interface between the environment and the genome |
Q27693287 | Epigenetic modifications: basic mechanisms and role in cardiovascular disease. |
Q38024759 | Epigenetic programming and risk: the birthplace of cardiovascular disease? |
Q37962574 | Epigenetic regulation by nuclear receptors |
Q36060346 | Epigenetic regulation of the calcitonin gene-related peptide gene in trigeminal glia. |
Q51831892 | Epigenetic regulation of the neural transcriptome: the meaning of the marks. |
Q37393053 | Epigenetic reprogramming: is deamination key to active DNA demethylation? |
Q33629585 | Epigenetic setting for long-term expression of estrogen receptor α and androgen receptor in cells. |
Q58669488 | Epigenetics and migraine |
Q33810295 | Epigenetics meets endocrinology |
Q24630397 | Establishing, maintaining and modifying DNA methylation patterns in plants and animals |
Q57262835 | Evolution of Eukaryotic Chromatin Proteins and Transcription Factors |
Q45000891 | First trimester vitamin D status and placental epigenomics in preeclampsia among Northern Plains primiparas |
Q38099074 | Functions of DNA methylation and hydroxymethylation in mammalian development |
Q38163235 | Fundamentals of vitamin D hormone-regulated gene expression |
Q39702263 | GCM1 regulation of the expression of syncytin 2 and its cognate receptor MFSD2A in human placenta |
Q37637391 | Gene regulation in the vascular endothelium: why epigenetics is important for the kidney |
Q37721503 | Genes, Gender, Environment, and Novel Functions of Estrogen Receptor Beta in the Susceptibility to Neurodevelopmental Disorders. |
Q57315843 | Genetic Influences on Circulating Vitamin D Level: A Review |
Q38065841 | Genome-wide association studies in asthma: what they really told us about pathogenesis |
Q37732576 | Genome-wide hypomethylation in cancer may be a passive consequence of transformation |
Q35230672 | Genome-wide principles of gene regulation by the vitamin D receptor and its activating ligand |
Q35892447 | Glucocorticoid-induced loss of DNA methylation in non-neuronal cells and potential involvement of DNMT1 in epigenetic regulation of Fkbp5. |
Q28394929 | Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis |
Q37961800 | Hormonal gene regulation through DNA methylation and demethylation |
Q37130533 | Hormonal programming across the lifespan |
Q37976064 | Hydroxylation mediates chromatin demethylation |
Q36795957 | Immune therapy and β-cell death in type 1 diabetes |
Q36668070 | Impaired vitamin D metabolism in CKD |
Q53907400 | Inadequate vitamin D status in pregnancy: evidence for supplementation. |
Q34629266 | Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing. |
Q31007525 | Insights into the programming of bone development from the Avon Longitudinal Study of Parents and Children (ALSPAC). |
Q36914953 | Intraindividual dynamics of transcriptome and genome-wide stability of DNA methylation |
Q33652604 | Introduction--Epiphanies in epigenetics. |
Q28269118 | Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis |
Q38904757 | KDM1A triggers androgen-induced miRNA transcription via H3K4me2 demethylation and DNA oxidation |
Q39479710 | KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells |
Q28564742 | LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription |
Q98621976 | Ligand-induced gene activation is associated with oxidative genome damage whose repair is required for transcription |
Q46988509 | Loss of methylation at the IFNG promoter and CNS-1 is associated with the development of functional IFN-γ memory in human CD4(+) T lymphocytes. |
Q28280293 | MBD4 and TDG: multifaceted DNA glycosylases with ever expanding biological roles |
Q49038288 | Mammalian Gcm genes induce Hes5 expression by active DNA demethylation and induce neural stem cells |
Q42872018 | Mammalian methyl-binding proteins: what might they do? |
Q36216886 | Maternal TET3 is dispensable for embryonic development but is required for neonatal growth |
Q21296718 | Mechanisms behind functional avidity maturation in T cells |
Q38013494 | Mechanisms of DNA methylation and demethylation in mammals |
Q33637461 | Meeting report: nuclear receptors: transcription factors and drug targets connecting basic research with translational medicine |
Q34609967 | Minireview: Extranuclear Steroid Receptors: Roles in Modulation of Cell Functions |
Q98394593 | Molecular and cellular basis of left-right asymmetry in vertebrates |
Q37845655 | Molecular coupling of DNA methylation and histone methylation |
Q38025329 | Molecular mechanisms of vitamin D action |
Q34025838 | Molecular targets of epigenetic regulation and effectors of environmental influences |
Q39686663 | Multigenerational programming in the glucocorticoid programmed rat is associated with generation-specific and parent of origin effects |
Q84453690 | Multiple post-translational modifications in hepatocyte nuclear factor 4α |
Q33878008 | Natural history of eukaryotic DNA methylation systems |
Q28567904 | Neonatal exposure to estradiol/bisphenol A alters promoter methylation and expression of Nsbp1 and Hpcal1 genes and transcriptional programs of Dnmt3a/b and Mbd2/4 in the rat prostate gland throughout life |
Q37840446 | Nuclear receptor coregulators merge transcriptional coregulation with epigenetic regulation. |
Q26849574 | Nuclear receptors and epigenetic regulation: opportunities for nutritional targeting and disease prevention |
Q36588163 | Oestrogen receptor β regulates epigenetic patterns at specific genomic loci through interaction with thymine DNA glycosylase. |
Q55058389 | On the origin of information in epigenetic structures in metazoans. |
Q38020424 | On the role of retinoblastoma family proteins in the establishment and maintenance of the epigenetic landscape |
Q28594421 | Opposing regulatory roles of phosphorylation and acetylation in DNA mispair processing by thymine DNA glycosylase |
Q38961914 | Oxytocin, a main breastfeeding hormone, prevents hypertension acquired in utero: A therapeutics preview. |
Q84077847 | PIAS4 represses vitamin D receptor-mediated signaling and acts as an E3-SUMO ligase towards vitamin D receptor |
Q37052396 | PTH/PTHrP and vitamin D control antimicrobial peptide expression and susceptibility to bacterial skin infection |
Q27349142 | Phenobarbital mediates an epigenetic switch at the constitutive androstane receptor (CAR) target gene Cyp2b10 in the liver of B6C3F1 mice |
Q28118804 | Phosphorylation of Williams syndrome transcription factor by MAPK induces a switching between two distinct chromatin remodeling complexes |
Q37855616 | Primary aldosteronism, diagnosis and treatment in Japan |
Q34260069 | Programming of DNA methylation patterns |
Q35153140 | Regulation and function of DNA methylation in plants and animals. |
Q37959635 | Regulation of intracrine production of 1,25-dihydroxyvitamin D and its role in innate immune defense against infection |
Q38356094 | Regulation of the vitamin D receptor gene by environment, genetics and epigenetics |
Q46745936 | Regulation of vitamin D metabolism |
Q28585429 | Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine |
Q49130490 | Retraction: DNA demethylation in hormone-induced transcriptional derepression |
Q38921717 | Role of Base Excision "Repair" Enzymes in Erasing Epigenetic Marks from DNA |
Q36249745 | Role of DNA methylation in the regulation of lipogenic glycerol-3-phosphate acyltransferase 1 gene expression in the mouse neonatal liver |
Q28262535 | Role of base excision repair in maintaining the genetic and epigenetic integrity of CpG sites |
Q37775594 | Setting and resetting of epigenetic marks in malignant transformation and development. |
Q35767260 | Sexual differentiation of the rodent brain: dogma and beyond |
Q35266388 | Single-stranded noncoding RNAs mediate local epigenetic alterations at gene promoters in rat cell lines. |
Q37742925 | Social Behavior of Pet Dogs Is Associated with Peripheral OXTR Methylation. |
Q43225233 | Stress-induced DNA methylation changes and their heritability in asexual dandelions. |
Q39353353 | TGF-β-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex |
Q37798252 | TGF-β: friend or foe? The role of TGF-β/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy. |
Q37898705 | Targeting Fas/FasL signaling, a new strategy for maintaining bone health |
Q51896182 | Targets and dynamics of promoter DNA methylation during early mouse development |
Q37946460 | The curious chemical biology of cytosine: deamination, methylation, and oxidation as modulators of genomic potential. |
Q35126213 | The degree of global DNA hypomethylation in peripheral blood correlates with that in matched tumor tissues in several neoplasia. |
Q37908840 | The growing role of gene methylation on endocrine function |
Q84998384 | The involvement of DNA and histone methylation in the repression of IL-1β-induced MCP-1 production by hypoxia |
Q36003426 | The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. |
Q37841833 | The path to epigenetic treatment of memory disorders. |
Q37878528 | The role for oxidative stress in aberrant DNA methylation in Alzheimer's disease |
Q37970067 | The role of methyl-binding proteins in chromatin organization and epigenome maintenance |
Q36761147 | The role of redox signaling in epigenetics and cardiovascular disease |
Q38388868 | The role of telomeres and vitamin D in cellular aging and age-related diseases |
Q37838638 | The vitamin D3 1alpha-hydroxylase gene and its regulation by active vitamin D3. |
Q24328865 | Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites |
Q24309357 | Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair |
Q35053261 | Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target? |
Q37851288 | Transcriptional controls by nuclear fat-soluble vitamin receptors through chromatin reorganization |
Q21558646 | Variant base excision repair proteins: contributors to genomic instability |
Q37993334 | Vitamin D actions to regulate calcium and skeletal homeostasis |
Q29392883 | Vitamin D and male reproduction |
Q59655772 | Vitamin D and multiple sclerosis |
Q37783308 | Vitamin D deficiency: universal risk factor for multifactorial diseases? |
Q39389302 | Vitamin D has wide regulatory effects on histone demethylase genes. |
Q37887993 | Vitamin D metabolism and activity in the parathyroid gland |
Q37887981 | Vitamin D metabolism within bone cells: effects on bone structure and strength |
Q37923110 | Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms |
Q47803355 | Vitamin D-mediated regulation of CYP21A2 transcription - a novel mechanism for vitamin D action |
Q83829854 | [Active DNA demethylation in mammals] |
Q49130490 | Retraction: DNA demethylation in hormone-induced transcriptional derepression | main subject | P921 |
Search more.